Vani Vallabhaneni, MD
Sleep Medicine · Austin, TXNPI 1447273644
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (48.5%), consulting fees and education — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Itamar Medical Inc at 45.6% of the total. Reporting peaked in 2020 at $1,751 and has fallen 78.5% since, to $376 in 2025.
Across 74 payments — averaging $45.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Itamar Medical Inc$2K
- Harmony Biosciences LLC$912
- Jazz Pharmaceuticals Inc.$440
- Avadel CNS Pharmaceuticals, LLC$200
- Inspire Medical Systems, Inc.$100
- Axsome Therapeutics, Inc.$76
- plus $105 from 5 others
What the payments were for
- Consulting fees$1,53546%
- Food & beverage$1,63549%
- Education$2006%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Itamar Medical Inc | 2 | $1,535 |
| Harmony Biosciences LLC | 28 | $912 |
| Jazz Pharmaceuticals Inc. | 18 | $440 |
| Avadel CNS Pharmaceuticals, LLC | 12 | $200 |
| Inspire Medical Systems, Inc. | 4 | $100 |
| Axsome Therapeutics, Inc. | 5 | $76 |
| Eisai Inc. | 1 | $35 |
| Resmed Corp | 1 | $27 |
| Philips North America LLC | 1 | $22 |
| ZOLL Respicardia, Inc. | 1 | $18 |
| 3b Medical, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,370 in reported general payments places this provider in the 70th percentile of 112 sleep medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Zolpidem Tartrate | 17 | $146 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Austin
- Ashwin GowdaAustin$71K
- Bhavim DesaiAustin$17K
- John HudsonAustin$16K
- Gerard MeskillSugar Land$1M
- Vikas JainFrisco$673K
- Amit VermaHouston$493K
- Jerald SimmonsHouston$165K
- James AndrySan Antonio$100K
- William BurkesBeaumont$99K
- John DebusDallas$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.